Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-11-10 Purchase | 2022-11-14 08:40 am | Roivant Sciences Ltd. | ROIV | Dexcel Pharma Technologies Ltd. Dexxon Holdings Ltd. Oren Dan 10% Owner | 4,000,000 | $5 | $20,000,000 | 102,849,443 (Direct) | View |
| 2022-04-22 Purchase | 2022-04-26 06:48 am | Roivant Sciences Ltd. | ROIV | Dexcel Pharma Technologies Ltd. Dexxon Holdings Ltd. Oren Dan 10% Owner | 40,285 | $3.8464 | $154,954 | 98,849,443 (Direct) | View |
| 2021-06-02 Sale | 2021-06-03 5:40 pm | Protalix BioTherapeutics Inc. | PLX | Dexcel Pharma Technologies Ltd. Oren Dan 10% Owner | 918,717 | $2.2737 | $2,088,857 | 3,637,314 (Direct) | View |
| 2020-01-31 Sale | 2020-02-04 6:41 pm | Intec Pharma Ltd. | NTEC | Dexcel Pharma Technologies Ltd. Oren Dan 10% Owner | 915,951 | $0.3075 | $281,659 | 4,234,897 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2021-10-01 5:02 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Dexcel Pharma Technologies Ltd. Dexxon Holdings Ltd. Oren Dan 10% Owner | 0 | $0 | 98,809,158 (Direct) | View |
Ownership | 2021-02-16 12:07 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Dexcel Pharma Technologies Ltd. Oren Dan 10% Owner | 0 | $0 | 7,372,932 (Direct) | View |